Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 13, Issue 5, 2014, Pages 579-584

  Terlizzi, V ^a   Tosco, A ^a   Tomaiuolo, R ^a,b   Sepe, A ^a   Amato, N ^a   Casale, A ^a   Mercogliano, C ^a   de Gregorio, F ^a   Improta, F ^a   Elce, A ^a,b   Castaldo, G ^a,b   Raia, V ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Children; Cystic fibrosis; Pancreatitis; PIP score

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PANCREATIC INSUFFICIENCY PREVALENCE SCORE; SCORING SYSTEM; SWEAT; SWEAT CHLORIDE TEST; ACUTE DISEASE; COMPLICATION; FEMALE; FORECASTING; MALE; PANCREATITIS; PATHOPHYSIOLOGY; RECURRENT DISEASE; RISK;

ACUTE DISEASE; ADOLESCENT; CHILD; CYSTIC FIBROSIS; FEMALE; FORECASTING; HUMANS; MALE; ODDS RATIO; PANCREATITIS; RECURRENCE; RISK;

EID: 84926107843     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.01.007     Document Type: Article

References (24)

1. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
2. Wolfenden L.L., Schechter M.S. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev 2009, 10:32-36.
3. Amato F., Bellia C., Cardillo G., Castaldo G., Ciaccio M., Elce A., et al. Extensive molecular analysis of patients bearing CFTR-related disorders. J Mol Diagn 2012, 14:81-89.
4. Castaldo G., Polizzi A., Tomaiuolo R., Cazeneuve C., Girodon E., Santostasi T., et al. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann Hum Genet 2005, 69:15-24.
5. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 53:S4-S14.
6. Durno C., Corey M., Zielenski J., Tullis E., Tsui L.C., Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002, 123:1857-1864.
7. De Boeck K., Wilschanski M., Castellani C., Taylor C., Cuppens H., Dodge J., et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006, 61:627-635.
8. Augarten A., Ben Tov A., Madgar I., Barak A., Akons H., Laufer J., et al. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype. Eur J Gastroenterol Hepatol 2008, 20:164-168.
9. De Boeck K., Weren M., Proesmans M., Kerem E. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 2005, 115:463-469.
10. Ooi C.Y., Durie P.R. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J Cyst Fibros 2012, 11:355-362.
11. Ooi C.Y., Dorfman R., Cipolli M., Gonska T., Castellani C., Keenan K., et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011, 140:153-156.
12. Morinville V.D., Husain S.Z., Bai H., Barth B., Alhosh R., Durie P.R., et al. Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr 2012, 55:261-265.
13. Keim V., Witt H., Bauer N., Bodeker H., Rosendahl J., Teich N., et al. The course of genetically determined chronic pancreatitis. JOP 2003, 4:146-154.
14. Rebours V., Boutron-Ruault M.C., Schnee M., Férec C., Le Maréchal C., Hentic O., et al. The natural history of hereditary pancreatitis: a national series. Gut 2009, 58:97-103.
15. Sultan M., Werlin S., Venkatasubramani N. Genetic prevalence and characteristics in children with recurrent pancreatitis. J Pediatr Gastroenterol Nutr 2012, 54:645-650.
16. Dequeker E., Stuhrmann M., Morris M.A., Casals T., Castellani C., Claustres M., et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders - updated European recommendations. Hum Genet 2009, 17:51-65.
17. Loser C., Mollgaard A., Folsch U.R. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996, 39:580-586.
18. Wali P.D., Loveridge-Lenza B., He Z., Horvath K. Comparison of fecal elastase-1 and pancreatic function testing in children. J Pediatr Gastroenterol Nutr 2012, 54:277-280.
19. Whitcomb D.C. Genetic aspects of pancreatitis. Annu Rev Med 2010, 61:413-424.
20. Couper R.T., Corey M., Moore D.J., Fisher L.J., Forstner G.G., Durie P.R. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res 1992, 32:179-182.
21. Gilljam M., Ellis L., Corey M., Zielenski J., Durie P., Tullis D.E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004, 126:1215-1224.
22. Schneider A., Larusch J., Sun X., Aloe A., Lamb J., Hawes R., et al. Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. Gastroenterology 2011, 140:162-171.
23. Ooi C.Y., Gonska T., Durie P.R., Freedman S.D. Genetic testing in pancreatitis. Gastroenterology 2010, 138:2202-2206.
24. Keim V. Role of genetic disorders in acute recurrent pancreatitis. World J Gastroenterol 2008, 14:1011-1015.